Diagnosis and Management of Comorbid Depression in Patients with Kidney Disease

Dates and Times

Start: 4/8/2025 11:00 AM
End: 4/8/2025 12:00 PM

Objectives

1) Recognize that depressive symptoms and major depressive disorder (MDD) are prevalent in patients with chronic kidney disease and end-stage kidney disease and are associated with adverse clinical outcomes.

2) Recognize that some of the symptoms of depression may overlap with the somatic symptoms of advanced chronic kidney disease and identify the screening tools and validated cutoffs for MDD in patients with chronic kidney disease and end-stage kidney disease.

3) Identify the potential adverse effects associated with commonly used antidepressant medication classes in patients with advanced chronic kidney disease.

4) Review the evidence for treatment of MDD in patient populations with kidney disease.

Grand Round Files

Speakers

Location

HSC, T-10, 021 Large Conf Room
Stony Brook University
Stony Brook, NY 11794

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Disclosure

The planners, speakers and reviewers have no relevant financial relationship with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients.